sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 02/06/2011
PIL Lantus 100 Units/ml solution for injection in a cartridge

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/08/2010 and displayed until 02/06/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 04/08/2010 and displayed until 16/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 22/10/2009 and displayed until 04/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 29/04/2008 and displayed until 22/10/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 20/09/2007 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to Further Information section
  • Correction of spelling/typing errors
Updated on 17/08/2006 and displayed until 20/09/2007
Reasons for adding or updating:
  • Company name change or merger
  • Correction of spelling/typing errors
Updated on 11/07/2006 and displayed until 17/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   insulin glargine